about
High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cellsCo-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes.Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506)Advanced-stage Hodgkin lymphoma: US/chest radiography for detection of relapse in patients in first complete remission--a randomized trial of routine surveillance imaging procedures.WT1-mediated repression of the proapoptotic transcription factor ZNF224 is triggered by the BCR-ABL oncogeneUp-regulated MSI2 is associated with more aggressive chronic myeloid leukemia.Selective strong synergism of Ruxolitinib and second generation tyrosine kinase inhibitors to overcome bone marrow stroma related drug resistance in chronic myelogenous leukemia.SHP-1 expression accounts for resistance to imatinib treatment in Philadelphia chromosome-positive cells derived from patients with chronic myeloid leukemia.Overcoming Challenges in CAR T-cell Product CGMP Release.Gene therapy to improve function of T cells for adoptive immunotherapy.Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia.A novel MLL/AF4 fusion gene lacking the AF4 transactivating domain in infant acute lymphoblastic leukemiaStimuli-responsive nanoparticle-assisted immunotherapy: a new weapon against solid tumours
P50
Q33806895-B77EB36B-A3B3-448F-A482-4016DCF054BFQ36059585-627AA40D-4084-410E-85EF-F8EAFEDA242CQ37450543-809DCAA5-D64E-48B4-9C85-1709C12B8A65Q38202697-CCD44FFE-784D-47C6-93B8-AE13CDBD055FQ38839647-CE60CD0E-97AC-4C4B-A74D-17E674CF98B1Q38943340-FAF6F799-3B6C-4A4E-94DF-BF9C842D19BDQ39054053-984F2AEE-CEE9-4337-8672-62BF8CA948BBQ39494051-76EA7438-44EB-4040-AF35-B10C1E950835Q42758892-C4D58A50-3567-43D0-A940-4DD3B7FC3344Q44989576-F0F34645-9605-424E-B6EA-9105F55A858CQ45296433-149BA7A0-E23E-457F-BE0A-7DB9795C739EQ78519569-D6AD91CB-FA07-44EA-8FD8-FE7563CA69C5Q89748944-38E6CE69-3916-4195-A41A-BEC7B2668415
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Concetta Quintarelli
@ast
Concetta Quintarelli
@en
Concetta Quintarelli
@es
Concetta Quintarelli
@nl
type
label
Concetta Quintarelli
@ast
Concetta Quintarelli
@en
Concetta Quintarelli
@es
Concetta Quintarelli
@nl
prefLabel
Concetta Quintarelli
@ast
Concetta Quintarelli
@en
Concetta Quintarelli
@es
Concetta Quintarelli
@nl
P106
P1153
22942060000
P31
P496
0000-0002-4343-9705